By the end of this module learners will be able to apply the knowledge presented in “Administering a Novel Recombinant Quadrivalent Influenza Vaccine (SupemtekTM) through Direct Orders in Ontario” to:

• Understand the novel recombinant quadrivalent influenza vaccine SupemtekTM and its place in immunotherapy
• Understand the status of SupemtekTM in both the National Advisory Committee on Immunization (NACI) Canadian Immunization Guide for Seasonal Influenza Vaccine for 2022-23 and the Ontario Universal Influenza Immunization Program (UIIP) for 2022-23
• Understand how the status of SupemtekTM in the Ontario 2022-23 UIIP and Pharmacist Scope of Practice for immunizations makes the requirement of a direct order necessary for pharmacist administration
• Understand direct orders and how to request, obtain, and document a direct order to administer SupemtekTM
• Identify patients who may benefit from the administration of SupemtekTM and discuss with them their options for influenza vaccines for 2022-23
• Utilize a Plan-Implement-Perform strategy and best practice advice for providing SupemtekTM to your patients during the 2022-23 influenza immunization program